Kiniksa Pharmaceuticals International, plc
KNSA
43 insider filings · Latest: Sep 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Apr 6 8:55 PM | Quart Barry D | Proposed Sale | 20,000 | $50.00 | $1.0M | — | View → |
| Apr 6, 2026 | Apr 6 8:54 PM | Patel Sanj K | Proposed Sale | 219,591 | $50.00 | $11.0M | — | View → |
| Apr 6, 2026 | Apr 6 8:04 PM | Moat Ross | Proposed Sale | 2,367 | $48.58 | $115.0K | — | View → |
| Mar 9, 2026 | Mar 11 8:38 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Sale | 36,722 | $45.92 | $1.7M | 12,086(D) | View → |
| Mar 9, 2026 | Mar 9 9:24 PM | Ragosa Mark | Proposed Sale | 36,722 | $45.92 | $1.7M | — | View → |
| Mar 2, 2026 | Mar 4 9:40 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Sale | 40,000 | $44.82 | $1.8M | 61,324(D) | View → |
| Mar 2, 2026 | Mar 2 10:22 PM | Paolini John F. | Proposed Sale | 40,000 | $44.82 | $1.8M | — | View → |
| Feb 12, 2026 | Feb 12 9:34 PM | Barry D QuartDirector | Sale | 2,690 | $45.00 | $121.0K | 12,546(D) | View → |
| Feb 10, 2026 | Feb 12 9:34 PM | Barry D QuartDirector | Sale | 110 | $45.00 | $5.0K | 12,546(D) | View → |
| Feb 9, 2026 | Feb 11 9:38 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Sale | 17,845 | $43.28 | $772.3K | 12,086(D) | View → |
| Feb 4, 2026 | Feb 4 11:24 PM | Barry D QuartDirector | Sale | 2,602 | $45.02 | $117.1K | 12,546(D) | View → |
| Feb 3, 2026 | Feb 4 11:24 PM | Barry D QuartDirector | Sale | 12,528 | $45.27 | $567.1K | 12,546(D) | View → |
| Feb 2, 2026 | Feb 4 11:24 PM | Barry D QuartDirector | Sale | 830 | $45.00 | $37.4K | 12,546(D) | View → |
| Dec 15, 2025 | Dec 15 10:13 PM | Quart Barry D | Proposed Sale | 58,889 | $41.51 | $2.4M | — | View → |
| Dec 8, 2025 | Dec 8 10:06 PM | Ragosa Mark | Proposed Sale | 72,686 | $41.49 | $3.0M | — | View → |
| Nov 26, 2025 | Nov 26 10:24 PM | Tessari Eben | Proposed Sale | 48,384 | $42.89 | $2.1M | — | View → |
| Nov 17, 2025 | Nov 17 10:07 PM | Tessari Eben | Proposed Sale | 12,470 | $41.24 | $514.2K | — | View → |
| Oct 31, 2025 | Oct 31 9:15 PM | Paolini John F. | Proposed Sale | 82,542 | $37.14 | $3.1M | — | View → |
| Oct 28, 2025 | Oct 28 8:54 PM | Ragosa Mark | Proposed Sale | 20,000 | $41.00 | $820.0K | — | View → |
| Oct 28, 2025 | Oct 28 8:52 PM | Ragosa Mark | Proposed Sale | 20,000 | $41.00 | $820.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Sep 3 8:49 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 9,104 | — | 0(D) | View → |
| Sep 1, 2026 | Sep 3 8:49 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Grant/Award | 38,950 | $79.28 | 31,150(D) | View → |
| Sep 1, 2026 | Sep 3 8:48 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Grant/Award | 150,200 | $79.28 | 120,150(D) | View → |
| Sep 1, 2026 | Sep 3 8:48 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Option Exercise | 31,318 | — | 0(D) | View → |
| Sep 1, 2026 | Sep 3 8:46 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Grant/Award | 150,200 | $79.28 | 120,150(D) | View → |
| Sep 1, 2026 | Sep 3 8:46 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Option Exercise | 31,318 | — | 0(D) | View → |
| Sep 1, 2026 | Sep 3 8:43 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Option Exercise | 8,328 | — | 0(D) | View → |
| Sep 1, 2026 | Sep 3 8:43 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Grant/Award | 33,450 | $79.28 | 26,750(D) | View → |
| Sep 1, 2026 | Sep 3 8:41 PM | Ross MoatCHIEF OPERATING OFFICER | Option Exercise | 8,285 | — | 0(D) | View → |
| Sep 1, 2026 | Sep 3 8:41 PM | Ross MoatCHIEF OPERATING OFFICER | Grant/Award | 46,200 | $79.28 | 36,950(D) | View → |
| Sep 1, 2026 | Sep 3 8:40 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Grant/Award | 18,250 | $79.28 | 14,600(D) | View → |
| Sep 1, 2026 | Sep 3 8:40 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Option Exercise | 11,496 | — | 0(D) | View → |
| Aug 1, 2026 | Aug 4 8:40 PM | Richard S LevyDirector | Grant/Award | 403 | — | 403(D) | View → |
| Aug 1, 2026 | Aug 4 8:40 PM | Richard S LevyDirector | Option Exercise | 403 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 8:42 PM | Dhiraj H MalkaniCHIEF STRATEGY OFFICER | Grant/Award | 103,459 | $62.88 | 0(D) | View → |
| May 29, 2026 | Jun 2 8:52 PM | Barry D QuartDirector | Option Exercise | 2,799 | — | 0(D) | View → |
| May 29, 2026 | Jun 2 8:52 PM | Barry D QuartDirector | Grant/Award | 14,184 | $48.38 | 2,026(D) | View → |
| May 29, 2026 | Jun 2 8:51 PM | Kimberly J PopovitsDirector | Option Exercise | 2,799 | — | 0(D) | View → |
| May 29, 2026 | Jun 2 8:51 PM | Kimberly J PopovitsDirector | Grant/Award | 14,184 | $48.38 | 2,026(D) | View → |
| Jun 1, 2026 | Jun 2 8:50 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Conversion | 900,000 | — | 626,160(I) | View → |
Page 1 of 4
Next →